Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angeliki Margoni

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Cellular and Molecular Medicine|May 28, 2025
Genetic Signature of Breast Cancer Defines Therapeutic Interventions and Indicates Early Drug ResistanceAngeliki Margoni, Kostas A Papavassiliou, Athanasios G Papavassiliou
Eye (London, England)|November 2, 2025
Transcription factor 4 and Fuchs' endothelial corneal dystrophy (FECD) association: Perspectives for novel targeted therapeuticsAngeliki Margoni, Kostas A Papavassiliou, Athanasios G Papavassiliou
Oral Oncology|January 3, 2026
Harnessing TP53 mutational status to enhance prognostic precision and therapeutic effectiveness in head and neck squamous cell carcinomaAngeliki Margoni, Kostas A Papavassiliou, Athanasios G Papavassiliou
Journal of Ovarian Research|August 10, 2024
CA-125:CA72-4 ratio - towards a promising cost-effective tool in ovarian cancer diagnosis and monitoring of post-menopausal women under hormone treatmentAngeliki Margoni, Antonios N Gargalionis, Athanasios G Papavassiliou
Diagnostics (Basel, Switzerland)|July 15, 2026
Tracking Bone Loss in GLP-1RA Therapy: The Potential of the Deoxypyridinoline Urine TestAngeliki Margoni, Efthimia K Basdra, Athanasios G Papavassiliou
Respiratory Research|February 12, 2026
Decoding pulmonary risk in childhood-onset still's disease: immunogenetic determinants and implications for risk stratificationAngeliki Margoni, Lampros Fotis, Kostas A Papavassiliou, et al.
Journal of Cellular and Molecular Medicine|July 14, 2026
ROS and Antioxidants: Prospective Therapeutic Options in CancerKostas A Papavassiliou, Amalia A Sofianidi, Angeliki Margoni, et al.
International Journal of Molecular Sciences|March 28, 2026
Biologically Informed Treatment Approaches Toward Personalized Therapeutic Strategies in Lung CancerKostas A Papavassiliou, Amalia A Sofianidi, Angeliki Margoni, et al.
Diagnostics (Basel, Switzerland)|April 14, 2026
Serum Bilirubin as a Prognostic Factor in Lung CancerAntonios N Gargalionis, Kostas A Papavassiliou, Angeliki Margoni, et al.
Biomolecules|November 27, 2025
Emerging Issues Regarding the Effects of the Microbiome on Lung Cancer ImmunotherapyKostas A Papavassiliou, Amalia A Sofianidi, Fotios G Spiliopoulos, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Cellular and Molecular Medicine|May 28, 2025
Genetic Signature of Breast Cancer Defines Therapeutic Interventions and Indicates Early Drug ResistanceAngeliki Margoni, Kostas A Papavassiliou, Athanasios G Papavassiliou
Eye (London, England)|November 2, 2025
Transcription factor 4 and Fuchs' endothelial corneal dystrophy (FECD) association: Perspectives for novel targeted therapeuticsAngeliki Margoni, Kostas A Papavassiliou, Athanasios G Papavassiliou
Oral Oncology|January 3, 2026
Harnessing TP53 mutational status to enhance prognostic precision and therapeutic effectiveness in head and neck squamous cell carcinomaAngeliki Margoni, Kostas A Papavassiliou, Athanasios G Papavassiliou
Journal of Ovarian Research|August 10, 2024
CA-125:CA72-4 ratio - towards a promising cost-effective tool in ovarian cancer diagnosis and monitoring of post-menopausal women under hormone treatmentAngeliki Margoni, Antonios N Gargalionis, Athanasios G Papavassiliou
Diagnostics (Basel, Switzerland)|July 15, 2026
Tracking Bone Loss in GLP-1RA Therapy: The Potential of the Deoxypyridinoline Urine TestAngeliki Margoni, Efthimia K Basdra, Athanasios G Papavassiliou
Respiratory Research|February 12, 2026
Decoding pulmonary risk in childhood-onset still's disease: immunogenetic determinants and implications for risk stratificationAngeliki Margoni, Lampros Fotis, Kostas A Papavassiliou, et al.
Journal of Cellular and Molecular Medicine|July 14, 2026
ROS and Antioxidants: Prospective Therapeutic Options in CancerKostas A Papavassiliou, Amalia A Sofianidi, Angeliki Margoni, et al.
International Journal of Molecular Sciences|March 28, 2026
Biologically Informed Treatment Approaches Toward Personalized Therapeutic Strategies in Lung CancerKostas A Papavassiliou, Amalia A Sofianidi, Angeliki Margoni, et al.
Diagnostics (Basel, Switzerland)|April 14, 2026
Serum Bilirubin as a Prognostic Factor in Lung CancerAntonios N Gargalionis, Kostas A Papavassiliou, Angeliki Margoni, et al.
Biomolecules|November 27, 2025
Emerging Issues Regarding the Effects of the Microbiome on Lung Cancer ImmunotherapyKostas A Papavassiliou, Amalia A Sofianidi, Fotios G Spiliopoulos, et al.
Pageof 3